Fortschritte der Neurologie-Psychiatrie
AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders
Abstract
Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.
Source and rights
Published by Fortschritte der Neurologie-Psychiatrie, 2004. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2004
- Applies to
- 🇩🇪 Germany
- Scope
- National
- Journal
- Fortschritte der Neurologie-Psychiatrie
- PubMed
- 15580533
- Added to Prognia
- 23 July 2026
More in other
- The Canine Cognitive Dysfunction Syndrome Working Group guidelines for diagnosis and monitoring of canine cognitive dysfunction syndromeEuropean Respiratory Society · 2026
- Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
